These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Levetiracetam in tardive dyskinesia: an open label study. Konitsiotis S; Pappa S; Mantas C; Mavreas V Mov Disord; 2006 Aug; 21(8):1219-21. PubMed ID: 16637037 [TBL] [Abstract][Full Text] [Related]
25. Do partial agonists cause akathisia: the role of the mental health nurse who prescribes. Jones M; Jones A J Psychiatr Ment Health Nurs; 2008 Jun; 15(5):417-23. PubMed ID: 18454828 [No Abstract] [Full Text] [Related]
26. Informed consent and tardive dyskinesia. Long-term follow-up. Kleinman I; Schachter D; Jeffries J; Goldhamer P J Nerv Ment Dis; 1996 Sep; 184(9):517-22. PubMed ID: 8831640 [TBL] [Abstract][Full Text] [Related]
27. What factors influence healthcare professionals' opinion and attitude regarding information for patients about hospital infection? Merle V; Tavolacci MP; Moreau A; Dubreuil N; Dollois B; Gray C; Kerleau K; Théry S; Czernichow P J Hosp Infect; 2007 Jul; 66(3):269-74. PubMed ID: 17574303 [TBL] [Abstract][Full Text] [Related]
28. Role of mirtazapine in the treatment of antipsychotic-induced akathisia. Hieber R; Dellenbaugh T; Nelson LA Ann Pharmacother; 2008 Jun; 42(6):841-6. PubMed ID: 18460588 [TBL] [Abstract][Full Text] [Related]
29. Mental health clinicians' beliefs about medicines, attitudes, and expectations of improved medication adherence in patients. Byrne MK; Deane FP; Caputi P Eval Health Prof; 2008 Dec; 31(4):390-403. PubMed ID: 18826984 [TBL] [Abstract][Full Text] [Related]
30. Psychiatrists' documentation of informed consent. Schachter D; Kleinman I Can J Psychiatry; 1998 Dec; 43(10):1012-7. PubMed ID: 9868566 [TBL] [Abstract][Full Text] [Related]
31. [Autonomy, privacy and informed consent: a BIOMED II Research Project with patients and nursing personnel in 5 European countries]. Arndt M; Välimäki M; Leino-Kilpi H; Scott A; Dassen T; Gasull M; Lemonidou C Pflege Z; 2002 Jan; 55(1):suppl 2-12. PubMed ID: 12630181 [No Abstract] [Full Text] [Related]
32. Neuroleptic-induced acute and chronic akathisia: a clinical comparison. Kim JH; Jin YH; Kang UG; Ahn YM; Ha KS; Kim YS Mov Disord; 2005 Dec; 20(12):1667-70. PubMed ID: 16078203 [TBL] [Abstract][Full Text] [Related]
33. Drug-induced movement disorders in children. Gilbert DL Ann N Y Acad Sci; 2008 Oct; 1142():72-84. PubMed ID: 18990122 [TBL] [Abstract][Full Text] [Related]
34. Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes. Chouinard G; Chouinard VA Psychother Psychosom; 2008; 77(2):69-77. PubMed ID: 18230939 [No Abstract] [Full Text] [Related]
35. [Akathisia--a state of agitation caused by drug]. Lauerma H Duodecim; 2000; 116(13):1383-5; quiz 1385, 1415. PubMed ID: 12001361 [No Abstract] [Full Text] [Related]
37. Molecule of the month. Paliperidone. Drug News Perspect; 2007 Jun; 20(5):333. PubMed ID: 17878961 [No Abstract] [Full Text] [Related]
38. Psychiatrists' documentation of informed consent: a representative survey. Schachter D; Kleinman I Can J Psychiatry; 2006 Jun; 51(7):438-44. PubMed ID: 16838825 [TBL] [Abstract][Full Text] [Related]
39. Drug information disclosed to patients prescribed antipsychotic medication. Benson PR J Nerv Ment Dis; 1984 Nov; 172(11):642-53. PubMed ID: 6149255 [TBL] [Abstract][Full Text] [Related]
40. Association of subjective cognitive dysfunction with akathisia in patients receiving stable doses of risperidone or haloperidol. Kim JH; Byun HJ J Clin Pharm Ther; 2007 Oct; 32(5):461-7. PubMed ID: 17875112 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]